Management of relapsed or refractory hodgkin lymphoma with second-generation antibody-drug conjugates: focus on brentuximab vedotin.
| Image |  |
|---|---|
| Description | scientific article published on June 2014 |
| Author/s |
author: Matthew Mei |
| Publication date | June 1, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |